HAVN Life Sciences Inc. (OTCMKTS:HAVLF) Sees Significant Increase in Short Interest

HAVN Life Sciences Inc. (OTCMKTS:HAVLF) was the recipient of a significant increase in short interest during the month of August. As of August 31st, there was short interest totalling 19,500 shares, an increase of 747.8% from the August 15th total of 2,300 shares. Based on an average daily volume of 80,600 shares, the short-interest ratio is presently 0.2 days.

HAVN Life Sciences stock opened at $0.22 on Wednesday. HAVN Life Sciences has a 12-month low of $0.21 and a 12-month high of $1.25. The company has a 50-day moving average price of $0.30 and a 200 day moving average price of $0.47.

About HAVN Life Sciences

HAVN Life Sciences Inc, a biotechnology company, engages in the research and development of psychopharmacological products from plants and fungi. The company was founded in 2020 and is headquartered in Vancouver, Canada.

Read More: What are the risks of holding treasury bonds?

Receive News & Ratings for HAVN Life Sciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HAVN Life Sciences and related companies with MarketBeat.com's FREE daily email newsletter.